alpha-aminopyridine has been researched along with Airway Hyper-Responsiveness in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kertys, M; Kosutova, P; Medvedova, I; Mikolka, P; Mokra, D; Mokry, J; Urbanova, A | 1 |
| Hata, T; Iwasaki, H; Kato, T; Kobayashi, H; Matsuo, A; Matsushita, M; Ohta, T | 1 |
| Kim, JH; Kim, SW; Kim, TJ; Kim, YK; Kwon, SS; Lee, SY; Park, CK; Rhee, CK; Yoon, HK | 1 |
| Han, H; Lee, JH; Park, HJ; Park, JW; Park, KH; Park, YH; Sim, da W | 1 |
| Beume, R; Braun, A; Hoymann, HG; Korolewitz, R; Krug, N; Muller, M; Wollin, L | 1 |
| Beume, R; Bundschuh, DS; Marx, D; Wohlsen, A; Wollin, L | 1 |
| Celly, C; Chapman, RW; House, A; Hunter, JC; Jones, H; Lamca, J; Phillips, JE; Prelusky, D; Richard, J; Ting, P | 1 |
7 other study(ies) available for alpha-aminopyridine and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Effects of tadalafil (PDE5 inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in guinea pigs.
Topics: Aminopyridines; Animals; Benzamides; Biomarkers; Cyclopropanes; Guinea Pigs; Inflammation Mediators; Lung; Male; Organ Culture Techniques; Ovalbumin; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Random Allocation; Respiratory Hypersensitivity; Tadalafil; Treatment Outcome | 2017 |
JTE-852, a novel spleen tyrosine kinase inhibitor, blocks antigen-induced allergic reactions in rats.
Topics: Airway Obstruction; Aminopyridines; Animals; Antigens; Cytokines; Disease Models, Animal; Hypersensitivity; Male; Mast Cells; Nasal Mucosa; Protein-Tyrosine Kinases; Rats; Rats, Inbred BN; Respiratory Hypersensitivity; Sneezing; Spleen; Thiazoles | 2018 |
Effect of roflumilast on airway remodelling in a murine model of chronic asthma.
Topics: Airway Remodeling; Allergens; Aminopyridines; Animals; Anti-Asthmatic Agents; Asthma; Benzamides; Bronchoalveolar Lavage Fluid; Chronic Disease; Cyclopropanes; Cytokines; Disease Models, Animal; Female; Goblet Cells; Humans; Hydroxyproline; Immunoglobulin E; Lung; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; Respiratory Hypersensitivity; T-Lymphocyte Subsets | 2016 |
Roflumilast Ameliorates Airway Hyperresponsiveness Caused by Diet-Induced Obesity in a Murine Model.
Topics: Adiponectin; Aminopyridines; Animals; Benzamides; Cell Proliferation; Cyclopropanes; Cytokines; Diet; Disease Models, Animal; Leptin; Mice, Inbred C57BL; Models, Biological; Obesity; Ovalbumin; Pulmonary Fibrosis; Reactive Oxygen Species; Respiratory Hypersensitivity; T-Lymphocytes | 2016 |
Effects of the phosphodiesterase type 4 inhibitor roflumilast on early and late allergic response and airway hyperresponsiveness in Aspergillus-fumigatus-sensitized mice.
Topics: Aminopyridines; Animals; Antigens, Fungal; Aspergillus fumigatus; Asthma; Benzamides; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Eosinophils; Female; Leukocyte Count; Lymphocytes; Methacholine Chloride; Mice; Mice, Inbred BALB C; Neutrophils; Phosphodiesterase 4 Inhibitors; Pneumonia; Respiratory Hypersensitivity; Respiratory Mechanics | 2009 |
Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Animals; Benzamides; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Immunization; Male; Neutrophils; Nitriles; Ovalbumin; Phosphodiesterase Inhibitors; Pneumonia; Pyridines; Rats; Respiratory Hypersensitivity; Rolipram; Serotonin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Aminopyridines; Animals; Anti-Allergic Agents; Benzamides; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Lung; Ovalbumin; Peak Expiratory Flow Rate; Phosphodiesterase Inhibitors; Pulmonary Edema; Rats; Rats, Inbred BN; Respiratory Hypersensitivity; Time Factors; Vital Capacity | 2007 |